rethinkPeptides Search
Menu
Study breakdown

BPC-157 Improves Outcomes in Short Bowel Syndrome in Rats

evidence
The takeaway

BPC-157 improved adaptation and outcomes in short bowel syndrome rats, enhancing intestinal adaptation after massive bowel resection — a potential therapy for this devastating surgical condition.

Key finding

BPC-157 improved adaptation and outcomes in short bowel syndrome rats, enhancing intestinal adaptation after massive bowel resection — a potential the

What the researchers found

BPC-157 improved adaptation and outcomes in short bowel syndrome rats, enhancing intestinal adaptation after massive bowel resection — a potential therapy for this devastating surgical condition.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
BPC-157 Improves Outcomes in Short Bowel Syndrome in Rats
What was found?
BPC-157 improved adaptation and outcomes in short bowel syndrome rats, enhancing intestinal adaptation after massive bowel resection — a potential therapy for this devastating surgical condition.

Read the original research

Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.

Digestive diseases and sciences, 54(10), 2070-83

Citation

Sever, Marko; Klicek, Robert; Radic, Bozo; Brcic, Luka; Zoricic, Ivan; Drmic, Domagoj; Ivica, Mihovil; Barisic, Ivan; Ilic, Spomenko; Berkopic, Lidija; Blagaic, Alenka Boban; Coric, Marijana; Kolenc, Danijela; Vrcic, Hrvoje; Anic, Tomislav; Seiwerth, Sven; Sikiric, Predrag. (2009). Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.. Digestive diseases and sciences, 54(10), 2070-83. https://doi.org/10.1007/s10620-008-0598-y